The European Society of Gastrointestinal Endoscopy (ESGE) will soon issue a new set of guidelines on clinical utility and selection process of patients for colon capsule endoscopy (PillCam COLON 2).
PillCam COLON 2 is a product of Israel-based Given Imaging. The new guidelines will directly affect the applicability and maybe wider use of PillCam COLON 2. It will be published in the May edition of the official journal of the ESGE, Endoscopy.
President and CEO of Given Imaging, Mr. Homi Shamir said, "Many patients who should be screened are non-compliant
due to a variety of reasons and we believe PillCam COLON 2 offers an
important new option, providing the optimal balance of low risk,
convenience and high diagnostic accuracy. We are very pleased with the
publication of ESGE colon capsule endoscopy guidelines which will
support our efforts to educate physicians regarding the clinical utility and benefit of using PillCam COLON for certain patients for whom
colonoscopy might be risky including: patients taking blood thinning
medications, patients with a higher risk of cardiopulmonary events
during or after sedation, or those at risk of perforation. We continue
to see the role of PillCam COLON expand and these guidelines will help
support the broader launch of this product in Europe this year."